Menu
Exonate
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.
Drug discovery – wet AMD and cancer
School of Medicine
Profile
Exonate’s research in this area has identified therapeutic candidates for wet Age Related Macular Degeneration that can be administered as a simple eye drop, thereby over-coming the unpleasant need for monthly injections in the eye.
Competing injectable anti-VEGFdirected therapy currently constitutes the gold-standard treatment for wet Age Related Macular Degeneration (wAMD) and other neovascular diseases of the eye.
News and press releases
@ExonateUK on Twitter
Excellent article from Exonate’s Senior Scientist Cristina Gutierrez-Caballero in The Biochemist Vol.42 No.2
Excellent article from Exonate’s Senior Scientist Cristina Guttierrez-Cabellero in The Biochemist Vol.42 No.2
Really excited that our CEO, @CatherineBeech is representing us at #biotrinity conference 28th April-1st May she is joining a fantastic line-up of speakers and is featured in a 30-minute case study showcasing her career path, business strategy and the importance of a strong team
@RANZCO clinical #COVID19 guidance is to continue anti-VEGF injections and maximise treat and extend for high risk #DME #wetAMD patients. Eye drops that reduce hospital visits and maintain treatment frequency are now key to safely prevent vision loss #newnormal
RANZCO on Twitter
“RANZCO has put together COVID-19 FAQs on providing clinical eye care including guidance for primary care providers. Visit the page: https://t...
twitter.com
We firmly believe that defeating #COVID19 requires a collective effort from everyone working in healthcare, and remain committed to the healthcare professionals during #WHWWeek, and patients, as well as to our employees and communities.
We are incredibly proud to be supporting the 3rd @o2hventures o2H Innovation Conference in Ahmedabad this week. @sunilshah123 @prashantshah Our very own @Catherinebeech will be joining a brilliant lineup of speakers
#o2hCollaborativeInnovation #Biotech #WomenInSTEM #innovation
👀Sight – it’s the sense most people say they fear losing. What if sight-saving medicines could be made into a simpler form, one that would be easier to use? @ExonateUK is teaming up with @JanssenGlobal ⬇️ #JPM20
Thrilled to work with Janssen to progress our new eye drop treatment for retinal vascular diseases #eyedisease #retinopathy @JanssenGlobal @JNJInnovation
